Home/Recalls/FDA-D-0299-2026
FDA DrugsClass II

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton contain...

Published: February 4, 2026Recall ID: D-0299-2026Category: drugsCountry: US

Reason for Recall / Hazard

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Product Description & Identification

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2

Additional Source Details

FieldValue
CityPeapack
StateNJ
Openfda › Nui › 1N0000175576
Openfda › Nui › 2N0000175450
Openfda › Upc › 10359762005014
Openfda › Upc › 20359762005113
Openfda › Upc › 30359762444035
Openfda › UniiX4W7ZR7023
Openfda › RouteORAL
Openfda › Spl idbc3419a0-22a3-4eaf-a4f2-3133e9380663
Openfda › Brand nameMETHYLPREDNISOLONE
Openfda › Spl set id22dd75d6-f89a-44f7-8ca6-b64c4e9806dd
Openfda › Package ndc › 159762-4440-3
Openfda › Package ndc › 259762-4440-2
Openfda › Package ndc › 359762-0049-1
Openfda › Package ndc › 459762-0050-1
Openfda › Package ndc › 559762-0051-1
Openfda › Product ndc › 159762-0049
Openfda › Product ndc › 259762-4440
Openfda › Product ndc › 359762-0050
Openfda › Product ndc › 459762-0051
Openfda › Generic nameMETHYLPREDNISOLONE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameMETHYLPREDNISOLONE
Openfda › Pharm class epcCorticosteroid [EPC]
Openfda › Pharm class moaCorticosteroid Hormone Receptor Agonists [MoA]
Openfda › Manufacturer nameMylan Pharmaceuticals Inc.
Openfda › Application numberNDA011153
Openfda › Is original packagertrue
Event id98278
Address 1100 Route 206 North
Address 2N/A
Code infoLot # LG7675, Exp. Date Nov 2026
Postal code07977
Report date20260204
Product typeDrugs
Product quantity3456 cartons
Reason for recallLabeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260115
Initial firm notificationLetter
Center classification date20260128

Overview

  • Recalling FirmGreenstone Llc
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States
Official Agency Alert